Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
225.21
-2.48 (-1.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
37
38
Next >
Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others
November 14, 2022
Biogen rose on Roche's Alzheimer's failure as a potential competitor drops off the map.
Via
Investor's Business Daily
Nasdaq, S&P 500 Futures Pullback At Start Of New Trading Week As Rate Fears Return To Haunt; AMD, Tesla, Biogen, Eli Lilly, JD In Focus
November 14, 2022
The major U.S. index futures are pointing to a moderately lower opening on Wall Street on Monday, as optimism following a tamer inflation data gives way to apprehension. The yield on the benchmark...
Via
Benzinga
Why Shares Of Eli Lilly And Biogen Are Rallying Today
November 14, 2022
Shares of Biogen Inc. (NASDAQ: BIIB) and Eli Lilly & Co. (NYSE: LLY) are rallying in premarket trading on Monday despite the negative broader market sentiment.
Via
Benzinga
Why Are Healthcare Stocks Down Today?
November 11, 2022
Healthcare stocks are falling after a false tweet from a Twitter account impersonating Eli Lilly. Here's what this news means for investors.
Via
InvestorPlace
Elliott Wave Technical Analysis: Biogen Inc. - Thursday, Nov. 10
November 10, 2022
Looking for a clear three-wave move pullback before considering any long-term longs.
Via
Talk Markets
Is Biogen Poised for a Bull Run?
November 03, 2022
Biogen has been a market-beating stock this year, but can that trend continue?
Via
The Motley Fool
Biogen (BIIB) Q3 2022 Earnings Call Transcript
October 25, 2022
BIIB earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Biogen Raises Annual Guidance Despite Q3 Earning Impacted By Biosimilar Competition
October 25, 2022
Via
Benzinga
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
November 10, 2022
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.
Via
Investor's Business Daily
The Power of McKinsey
November 09, 2022
Author Michael Forsythe talks about his new book, "When McKinsey Comes to Town: The Hidden Influence of the World's Most Powerful Consulting Firm."
Via
The Motley Fool
Biogen To Rally Around 15%? Here Are 5 Other Price Target Changes For Tuesday
November 01, 2022
Mizuho raised Biogen Inc. (NASDAQ: BIIB) price target from $270 to $325. Mizuho analyst Salim Syed maintained the stock with a Buy rating. Biogen shares fell 0.3% to close at $283.44 on Monday.
Via
Benzinga
Don't Get Used to Lower Medicare Part B Premiums -- Here's Why
October 29, 2022
Medicare might have to begin paying billions of extra dollars for new drugs in the not-too-distant future.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Earnings Scheduled For October 25, 2022
October 25, 2022
Companies Reporting Before The Bell • UBS Gr (NYSE:UBS) is expected to report earnings for its third quarter. • SAP (NYSE:SAP) is expected to report earnings for its third quarter.
Via
Benzinga
15 Analysts Have This to Say About Biogen
October 24, 2022
Analysts have provided the following ratings for Biogen (NASDAQ:BIIB) within the last quarter:
Via
Benzinga
Stock Market Rally Resilient As Apple Bucks Megacap Meltdown: Weekly Review
October 28, 2022
The Dow and S&P 500 moved above a key level while the Nasdaq rose.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
Upgrades
Via
Benzinga
Biogen To Report Q3 Earnings: Here's What To Expect
October 21, 2022
Biogen will report third-quarter 2022 results on Oct 25, before market open.
Via
Talk Markets
Is Biogen a Buy After It Boosted Guidance?
October 26, 2022
There's a much bigger story for this biotech than its improved 2022 outlook.
Via
The Motley Fool
Biogen Inc. Surpasses Q3 Earnings And Revenue Estimates
October 25, 2022
Biogen Inc. came out with quarterly earnings of $4.77 per share.
Via
Talk Markets
Biogen Inches Higher On Third-Quarter Beat, But All Eyes Watch Alzheimer's Drug
October 25, 2022
Biogen's partner, Eisai, will present Phase 3 results for lecanemab next month.
Via
Investor's Business Daily
Recap: Biogen Q3 Earnings
October 25, 2022
Biogen (NASDAQ:BIIB) reported its Q3 earnings results on Tuesday, October 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Biogen beat estimated earnings by...
Via
Benzinga
Where Biogen Stands With Analysts
October 24, 2022
Over the past 3 months, 15 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Biogen Q3 Earnings Preview: Key Items For Investors To Watch
October 24, 2022
Biogen Inc (NASDAQ: BIIB) is scheduled to report its third-quarter earnings on Tuesday during the premarket session amid cautious hope for its neurodegenerative disease programs and an ongoing
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 24, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
October 24, 2022
Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.47% on an annualized basis producing an average annual return of 9.66%. Currently, Biogen has a market capitalization of...
Via
Benzinga
Earnings Preview: Biogen
October 24, 2022
Biogen (NASDAQ:BIIB) is set to give its latest quarterly earnings report on Tuesday, 2022-10-25. Here's what investors need to know before the announcement. Analysts estimate that Biogen will report an...
Via
Benzinga
3 Alzheimer's Therapy Stocks to Invest in
October 21, 2022
Alzheimer's treatments could make a big winner of these stocks.
Via
The Motley Fool
This Beaten-Down ETF Is Still a Screaming Bear-Market Buy
October 21, 2022
Investors wanting to profit from a potential biotech sector bounce should love this exchange-traded fund.
Via
The Motley Fool
Biogen Whale Trades For October 20
October 20, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 12 strange trades.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.